Mechanism and therapeutic efficacy of the XPO1 inhibitor selinexor in refractory/relapsed EBV-positive NK cell lymphoma
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Yaxian Ma, Yuhan Bao, Min Liu, Tongjuan Li, Qing Yin, Zetong Hong, Yan Feng, Jia Wei, Miao Zheng
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417016727
Cites:
Cited by:
Related to: